Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation
Identifieur interne : 001B09 ( Istex/Curation ); précédent : 001B08; suivant : 001B10Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation
Auteurs : C. Daubert [France] ; P. Mabo [France] ; D. Gras [France] ; C. Leclerco [France]Source :
- European Heart Journal [ 0195-668X ] ; 1993-11.
Abstract
Numerous trials performed over the last 20 years, although uncontrolled, have shown the racemic d,l-sotalol is effective for the acute conversion and for long-term prevention of recurrences of supraventricular tachyarrhythmias. Sotalol appeared to be moderately effective in atrial fibrillation or atrial flutter, having somewhat greater efficacy in the case of atrioventricular (AV) nodal re-entrant tachycardia due to Wolff-Parkinson-White syndrome or concealed accessory pathway. These effects may stem from the combined class II and class III electrophysiologic properties of this drug. However, studies comparing d,l-sotalol to pure beta blockers in different ‘models’, especially postsurgical arrhythmias and Wolff-Parkinson-White syndrome, have suggested that the observed clinical benefit may be related to d,l-sotalol's class III properties. Thus, d-sotalol may be efficacious in these indications. Its precise efficacy should be defined in controlled clinical trials.
Url:
DOI: 10.1093/eurheartj/14.suppl_H.67
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001B11
Links to Exploration step
ISTEX:E2AE7F383C55138A3F0C592F9BEBD5922363BFDBLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation</title><author><name sortKey="Daubert, C" sort="Daubert, C" uniqKey="Daubert C" first="C." last="Daubert">C. Daubert</name><affiliation wicri:level="1"><mods:affiliation>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex</wicri:regionArea></affiliation></author><author><name sortKey="Mabo, P" sort="Mabo, P" uniqKey="Mabo P" first="P." last="Mabo">P. Mabo</name><affiliation wicri:level="1"><mods:affiliation>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex</wicri:regionArea></affiliation></author><author><name sortKey="Gras, D" sort="Gras, D" uniqKey="Gras D" first="D." last="Gras">D. Gras</name><affiliation wicri:level="1"><mods:affiliation>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex</wicri:regionArea></affiliation></author><author><name sortKey="Leclerco, C" sort="Leclerco, C" uniqKey="Leclerco C" first="C." last="Leclerco">C. Leclerco</name><affiliation wicri:level="1"><mods:affiliation>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E2AE7F383C55138A3F0C592F9BEBD5922363BFDB</idno><date when="1993" year="1993">1993</date><idno type="doi">10.1093/eurheartj/14.suppl_H.67</idno><idno type="url">https://api.istex.fr/document/E2AE7F383C55138A3F0C592F9BEBD5922363BFDB/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001B11</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001B11</idno><idno type="wicri:Area/Istex/Curation">001B09</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation</title><author><name sortKey="Daubert, C" sort="Daubert, C" uniqKey="Daubert C" first="C." last="Daubert">C. Daubert</name><affiliation wicri:level="1"><mods:affiliation>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex</wicri:regionArea></affiliation></author><author><name sortKey="Mabo, P" sort="Mabo, P" uniqKey="Mabo P" first="P." last="Mabo">P. Mabo</name><affiliation wicri:level="1"><mods:affiliation>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex</wicri:regionArea></affiliation></author><author><name sortKey="Gras, D" sort="Gras, D" uniqKey="Gras D" first="D." last="Gras">D. Gras</name><affiliation wicri:level="1"><mods:affiliation>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex</wicri:regionArea></affiliation></author><author><name sortKey="Leclerco, C" sort="Leclerco, C" uniqKey="Leclerco C" first="C." last="Leclerco">C. Leclerco</name><affiliation wicri:level="1"><mods:affiliation>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Cardiologie, Hotel Dieu/Centre Hospitalier Regional et Universitaire, 35033 Rennes Cedex</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">European Heart Journal</title><idno type="ISSN">0195-668X</idno><idno type="eISSN">1522-9645</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="1993-11">1993-11</date><biblScope unit="volume">14</biblScope><biblScope unit="supplement">suppl_H</biblScope><biblScope unit="page" from="67">67</biblScope><biblScope unit="page" to="73">73</biblScope></imprint><idno type="ISSN">0195-668X</idno></series><idno type="istex">E2AE7F383C55138A3F0C592F9BEBD5922363BFDB</idno><idno type="DOI">10.1093/eurheartj/14.suppl_H.67</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0195-668X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Numerous trials performed over the last 20 years, although uncontrolled, have shown the racemic d,l-sotalol is effective for the acute conversion and for long-term prevention of recurrences of supraventricular tachyarrhythmias. Sotalol appeared to be moderately effective in atrial fibrillation or atrial flutter, having somewhat greater efficacy in the case of atrioventricular (AV) nodal re-entrant tachycardia due to Wolff-Parkinson-White syndrome or concealed accessory pathway. These effects may stem from the combined class II and class III electrophysiologic properties of this drug. However, studies comparing d,l-sotalol to pure beta blockers in different ‘models’, especially postsurgical arrhythmias and Wolff-Parkinson-White syndrome, have suggested that the observed clinical benefit may be related to d,l-sotalol's class III properties. Thus, d-sotalol may be efficacious in these indications. Its precise efficacy should be defined in controlled clinical trials.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B09 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001B09 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:E2AE7F383C55138A3F0C592F9BEBD5922363BFDB
|texte= Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation
}}
| This area was generated with Dilib version V0.6.29. |  |